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Recanalization of an occluded intracranial artery is influenced by temperature-dependent
enzymes, including alteplase. We assessed the relation between body temperature on
admission and recanalization.
Methods
We included 278 patients with acute ischaemic stroke within nine hours after symptom
onset, who had an intracranial arterial occlusion on admission CT angiography, in 13 partici-
pating centres. We calculated the relation per every 0.1°Celsius increase in admission body
temperature and recanalization at three days.
Results
Recanalization occurred in 80% of occluded arteries. There was no relation between body
temperature and recanalization at three days after adjustments for age, NIHSS score on
admission and treatment with alteplase (adjusted odds ratio per 0.1°Celsius, 0.99; 95%
confidence interval, 0.94–1.05; p = 0.70). Results for patients treated or not treated with
alteplase were essentially the same.
Conclusions
Our findings suggest that in patients with acute ischaemic stroke there is no relation
between body temperature on admission and recanalization of an occluded intracranial
artery three days later, irrespective of treatment with alteplase.
PLOS ONE | DOI:10.1371/journal.pone.0140777 October 16, 2015 1 / 6
OPEN ACCESS
Citation: Geurts M, van der Worp HB, Horsch AD,
Kappelle LJ, Biessels GJ, Velthuis BK, et al. (2015)
No Relation between Body Temperature and Arterial
Recanalization at Three Days in Patients with Acute
Ischaemic Stroke. PLoS ONE 10(10): e0140777.
doi:10.1371/journal.pone.0140777
Editor: Jean-Claude Baron, INSERM U894,
FRANCE
Received: July 29, 2015
Accepted: September 30, 2015
Published: October 16, 2015
Copyright: © 2015 Geurts et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: M. Geurts, H. B. van der Worp, and G. J.
Biessels are supported by the Dutch Heart
Foundation (2010B239, 2010T075, and 2010T073
respectively). The DUST study was supported by the
Dutch Heart Foundation (2008T034) and the
NutsOhra Foundation (0903-012).
Competing Interests: The authors have declared
that no competing interests exist.
Introduction
In patients with acute ischaemic stroke, recanalization of the occluded cerebral artery is strongly
associated with improved functional outcome [1]. Spontaneous recanalization is influenced by
temperature-dependent enzymes [2], and the in vitro activity of alteplase reduces with lower tem-
peratures [3]. Whether body temperature also affects in vivo recanalization with or without alte-
plase is uncertain. This might be important, because guidelines recommend the use of antipyretics
in stroke patients with fever [4, 5] and two phase III trials of therapeutic hypothermia for ischae-
mic stroke are in progress [6, 7]. We assessed the relation between body temperature and recanali-
zation in patients with acute ischaemic stroke, treated with or without intravenous alteplase.
Methods
This is a substudy of the Dutch acute Stroke study (DUST), a prospective multi-centre cohort
study including adult patients with acute ischemic stroke within nine hours after symptom
onset between May 2009 and July 2013. The design, eligibility criteria, and neuroimaging pro-
tocol have been reported previously [8]. All patients underwent non-contrast CT, CT perfu-
sion, and CT angiography (CTA) within 9 hours after symptom onset. In this substudy, we
included patients with visible intracranial arterial occlusion on admission CTA, and follow-up
vascular imaging at 3 (±2) days. Patients who received intra-arterial treatment were excluded.
Body temperature was recorded on admission.
Stroke severity at admission was assessed with the National Institutes of Health Stroke Scale
(NIHSS). Stroke subtype was recorded according to the Trial of Org 10172 in Acute Stroke
Treatment (TOAST) classification. Recanalization was assessed on follow-up vascular imaging
and classified as no recanalization on the one hand, or partial or complete recanalization on
the other. All scans were centrally evaluated by one of three experienced observers, who were
blinded for the clinical data except for the side of symptoms. Poor functional outcome was
defined as a modified Rankin Scale (mRS) score3 at 90 days.
Temperature data were retrospectively collected from patients’ charts by one investigator,
blinded for outcome measures. Body temperature on admission was defined as first recorded
body temperature within twelve hours after admission, measured either tympanic or rectal.
The medical ethics committee of the University Medical Center Utrecht approved the
DUST study, and written informed consent was obtained from each patient or a legal
representative.
Statistical analysis
The relation per 0.1°Celsius increase in admission body temperature and recanalization or
functional outcome was calculated by means of logistic regression with a generalized estimating
equations model, and expressed as an odds ratio (OR) with a corresponding 95% confidence
interval (CI). We adjusted for age, NIHSS score on admission and treatment with alteplase.
Pre-defined subgroup analyses were performed with regard to treatment with alteplase and
etiology of stroke. In a separate analysis patients were stratified according to the time of the sec-
ond CT angiography.
Finally, we performed two additional analyses assuming that either none or all of the
patients excluded because of no follow up imaging had recanalization.
Results
Of the 1393 patients in DUST, 643 had an occluded intracranial artery on admission CTA.
Reasons for exclusion for the present study were: no follow-up vascular imaging (n = 289), no
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admission body temperature recorded (n = 30), or intra-arterial treatment (n = 46). We
included 278 patients, with 288 occluded intracranial arteries. Patient characteristics are pre-
sented in Table 1.
Location of the most proximal part of the intracranial occlusion was middle cerebral artery
in 215 (75%) arteries, posterior cerebral artery in 30 (10%), the intracranial part of the internal
carotid artery in 18 (6%), anterior cerebral artery in 10 (4%), basilar artery in 8 (3%), and
another artery in 7 (2%) patients. Ten patients had more than one occluded intracranial
arteries.
Patients without follow-up imaging were older than patients with follow-up imaging (68
versus 65, P = 0.01), had higher NIHSS scores on admission (13 versus 11, P = 0.01), and had
worse outcomes (median mRS 3 versus 2, P<0.001).
Follow-up imaging was performed at a median of 3 days (IQR 2 days) after admission. Fol-
low-up imaging was CTA (95%) or MR angiography (5%). Recanalization occurred in 229
(80%) of occluded arteries. Partial or complete recanalization was associated with a better out-
come compared to no recanalization (median mRS 2 (IQR 3) versus 3 (IQR2), respectively;
P = 0.01).
Body temperature on admission was not associated with recanalization (OR per 0.1°C, 0.98;
95%CI, 0.93–1.03; P = 0.39; adjusted OR (aOR) per 0.1°C, 0.99; 95%CI, 0.94–1.05; P = 0.70)
(Table 2, Fig 1), nor with poor outcome (OR per 0.1°C, 0.97; 95%CI, 0.93–1.01; P = 0.09).
Because follow-up imaging was missing in a substantial proportion of patients who were
otherwise eligible for our study, we performed post-hoc analyses that modelled several scenar-
ios in these patients. In these post-hoc analyses, we included all patients with a visible intracra-
nial arterial occlusion on admission CTA, with or without follow up imaging. Patients who
received intra-arterial treatment were excluded. In a best case scenario assuming that all
patients without follow-up imaging had recanalization, body temperature on admission was
not associated with recanalization (aOR per 0.1°C, 0.99; 95%CI, 0.95–1.04; P = 0.67). The same
Table 1. Patient characteristics.
Baseline characteristics n = 278
Body temperature on admission (°C) 36.7 (0.6)
Age (years) 66 (14)
Female sex 122 (44)
NIHSS score on admission 11 (7)
Previous stroke 52 (19)
Hypertension 143 (51)
Stroke etiology (TOAST)
Large-artery atherosclerosis 118 (42)
Cardioembolism 69 (25)
Small vessel disease 0 (0)
Other 20 (7)
Unknown 71 (26)
Current smoking 90 (32)
Diabetes mellitus 28 (10)
Treatment with alteplase 187 (67)
Data are n (%), median (range), median (interquartile range (IQR)) or mean (standard deviation (SD))
where appropriate. NIHSS, National Institutes of Health Stroke Scale; TOAST, Trial of Org 10172 in Acute
Stroke Treatment classiﬁcation
doi:10.1371/journal.pone.0140777.t001
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was found in a worst case scenario assuming that none of the patients without follow-up imag-
ing had recanalization (aOR per 0.1°C, 1.01; 95%CI, 0.98–1.04; P = 0.50).
Results stratified by time of the second (follow-up) CT angiography are shown in S3 Table.
Subgroup analyses
Characteristics of patients in subgroups are presented in S1 and S2 Tables. Treatment with iv
alteplase was related to recanalization (aOR, 2.44; 95% CI, 1.33–4.28; P = 0.004).
There was neither difference in the relation between body temperature and recanalization
between patients treated or not treated with alteplase, nor between patients with large-artery
atherosclerosis and patients with cardioembolic stroke (Table 2).
Discussion
Our findings suggest that in patients with acute ischaemic stroke, there is no relation between
body temperature on admission and recanalization of an occluded intracranial artery three
days later, irrespective of treatment with alteplase.
Most reports on the relation between body temperature and clot lysis concern in vitro stud-
ies. These have shown a reduced rate of fibrinolysis by alteplase at lower temperatures [3].
However, in vitro studies may not adequately reflect the in vivo setting of an acute arterial
occlusion. Data from animal and human studies are limited. Some clinical studies found an
association between higher admission body temperatures and a favourable outcome after
Table 2. Results of unadjusted and adjusted logistic regression on the relation between body temperature and recanalization.
Unadjusted Adjusted for age, NIHSS, and
treatment with alteplase
Test of interaction
OR 95%CI p OR 95%CI P p
Overall analysis (n = 278) 0.98 0.93–1.03 0.39 0.99 0.94–1.05 0.70 NA
Subgroup analyses
Treatment with alteplase (n = 187) 1.02 0.94–1.11 0.66 1.03 0.93–1.13 0.60
No treatment with alteplase (n = 91) 0.96 0.90–1.04 0.32 0.97 0.90–1.04 0.33 0.20
Large artery atherosclerosis (n = 118) 0.94 0.87–1.01 0.10 0.95 0.87–1.03 0.22
Cardio-embolic (n = 69) 1.01 0.90–1.13 0.91 1.02 0.88–1.19 0.76 0.42
NIHSS, National Institutes of Health Stroke Scale; OR, odds ratio; CI, conﬁdence interval; NA, not applicable
doi:10.1371/journal.pone.0140777.t002
Fig 1. Odds ratios for the relation between body temperature on admission and recanalization.
doi:10.1371/journal.pone.0140777.g001
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thrombolysis with alteplase [9, 10], but others did not [11]. No studies have investigated
whether this was related to higher recanalization rates.
We did not find a relation between body temperature on admission and recanalization or
functional outcome. Other studies have suggested that increased body temperatures in the first
few days, rather than on admission, are related to poor outcome [12, 13].
This study has limitations. Body temperature was assessed at admission and recanalization
at three (± 2) days. Recanalization occurring after several hours may be of little or no benefit to
ischemic tissue, and clinical consequences of delayed recanalization are therefore limited [1].
Previous studies suggest that body temperatures during the first three days may also have
affected recanalization rates [14, 15]. However, in this study recanalization was strongly related
to alteplase treatment within 4.5 hours, suggesting that most recanalization occurs in the first
hours after stroke, and recanalization was associated with improved clinical outcome. The gen-
eralizability of our findings is hampered because in numerous patients missed follow-up imag-
ing, but this is unlikely to have a major effect on the findings in this explanatory rather than
prognostic study. We did not have data on the occurrence of infections in our population. The
inter- or intra-observer variability in the measurement of recanalization was also not deter-
mined.Finally, the vast majority of our study population had normal body temperatures. Due
to the limited variability in body temperatures, we could not assess associations between recan-
alization and body temperatures below 36.0°C or above 37.5°C.
Supporting Information
S1 Table. Baseline characteristics of patients treated and not treated with intravenous alte-
plase.
(DOCX)
S2 Table. Baseline characteristics of patients large-artery atherosclerosis and cardioembo-
lism etiology of stroke.
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S3 Table. Results of unadjusted and adjusted logistic regression on the relation between
body temperature and recanalization, stratified by time of the second CT angiography.
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